Jaws Acquisition Corp. today announced the effectiveness of its registration statement in connection with its pending merger with Cano Health. Jaws also set a June 2 meeting for a shareholder vote on the deal.
The transaction values Cano Health at an enterprise value of $4.4 billion and is expected to provide up to $1.49 billion in cash proceeds, including a fully committed PIPE of $800 million.
The PIPE includes $50 million from Barry Sternlicht, Chairman of Jaws, as well as commitments from funds affiliated with Fidelity Management & Research Company, funds and accounts managed by BlackRock, Third Point and Maverick Capital. Read more.
